Bcl-XL mutations suppress cellular sensitivity to antimycin A

J Biol Chem. 2004 Jan 16;279(3):2159-65. doi: 10.1074/jbc.M306021200. Epub 2003 Oct 8.

Abstract

Cells expressing high levels of the BCL-X(L) anti-apoptotic protein are preferentially killed by the mitochondrial inhibitor antimycin A (AA). Computational modeling predicts a binding site for AA in the extended hydrophobic groove on BCL-X(L), previously identified as an interface for dimerization to BAX and related proapoptotic proteins. Here, we identify BCL-X(L) hydrophobic groove mutants with normal cellular anti-apoptotic function but suppressed sensitivity to AA. The LD(50) of AA for cells expressing BCL-X(L) mutants directly correlates with the measured in vitro dissociation constants for AA binding. These results indicate that BCL-X(L) is a principal target mediating AA cytotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Antimycin A / pharmacology*
  • Binding Sites
  • Cell Survival / drug effects
  • Hydrophobic and Hydrophilic Interactions
  • Molecular Sequence Data
  • Point Mutation
  • Protein Folding
  • Proto-Oncogene Proteins c-bcl-2 / chemistry*
  • Proto-Oncogene Proteins c-bcl-2 / physiology
  • bcl-X Protein

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • bcl-X Protein
  • Antimycin A